GC
LinkedIn

Gwen Cheni

AI builder+investor | ex-Khosla, IndieBio, JPMorgan, Goldman, UCSF, Yale

United States · 1 connection

Connecticut Innovations

Not on Unlinked · Imported profile. Is this you? Claim it

About

Gwen Cheni is joining Khosla Ventures as a Partner on the investment team. She was previously a Partner at IndieBio/SOSV covering bio and AI. Prior to IndieBio, Gwen was raising her own synthetic biology fund, a Director at Studio X (machine learning venture studio by Shell and Boston Consulting Group), and a Venture Partner at Fusion Fund (early stage fund focused on AI/ML, robotics and medical devices). Gwen was on the Board of Advisors at Singularity University Ventures, an impact-focused accelerator, and helped launch their first batch of startups in the Nordics. Prior to venture, Gwen spent eighteen years on Wall Street investing in public equities, started her career at Goldman Sachs, JPMorgan, and was promoted to portfolio manager at a $300 million innovation-themed hedge fund. Gwen is bilingual in computer science programming languages and wet lab research protocols. On the computer science side, she received her bachelor’s degree in economics (math track) with a minor in computer science electrical engineering from Yale University. One of her four MBA concentrations from the University of Chicago was econometrics/statistical learning. She has completed all sixteen machine

Experience

Director (Investments)Connecticut Innovations
Nov 2025
PartnerKhosla Ventures
Feb 2022 to Jul 2023
Advisory Board MemberYale School of Medicine
Jan 2020 to Jun 2023
PartnerSOSV SF & NY (Fka IndieBio)
Feb 2021 to Feb 2022
Venture ConsultantGinkgo Bioworks
Nov 2019 to Feb 2021
Venture PartnerFusion Fund
Jun 2019 to Feb 2021
Member of the Board of Advisors, Entrepreneur in Residence (EIR)Singularity University
Jan 2017 to Mar 2020
Assistant Portfolio Manager, PartnerPier 88 Investment Partners Basic company page — company details not listed yet
Mar 2016 to Mar 2019
Equity Analyst, Vice PresidentBrown Brothers Harriman
Nov 2011 to Mar 2016
Equity AnalystLord Abbett
Mar 2009 to Nov 2011
Equity Research AnalystLegg Mason (Acquired by Franklin Templeton)
Apr 2008 to Mar 2009
Equity Research AssociateJ.P. Morgan
Aug 2004 to Apr 2008
AnalystGoldman Sachs
Jul 2001 to Sep 2002
Lab Researcher (Neuro-oncology + Immunology)UCSF Health
Sep 2002 to Feb 2004
Lab ResearcherUCSF Health
Jul 1999 to Sep 1999
ResearcherPrinceton University
May 1999 to Jul 1999
Lab ResearcherUniversity of Vermont
May 1996 to Aug 1996

Education

Yale University
Bachelor of Arts (BA) Economics (math track) Computer Science Electrical Engineering minor-equiv
1999 to 2001
The University of Chicago Booth School of Business
Master of Business Administration (MBA) Entrepreneurship Econometrics (Statistical Learning) Analytical Finance Accounting
2004 to 2006
DeepLearning.ai
Deep Learning Specialization
2020 to 2020
DeepLearning.ai
AI for Medicine Specialization
2020 to 2020
DeepLearning.ai
Natural Language Processing Certification
2020
DeepLearning.ai
Generative Adversarial Networks (GANs) Specialization
2020 to 2021
University of Alberta
Reinforced Learning Specialization
2021 to 2021
The Johns Hopkins University
Genomic Data Science Specialization
2021
University of Washington
Machine Learning Specialization Machine Learning Specialization
2022
DeepLearning.AI
Machine Learning Engineering for Production (MLOps) Specialization
2023